Pubertal development in HIV-infected African children on first-line antiretroviral therapy

AIDS

Volumn 29, Issue 5, 2015, Pages 609-618

  Szubert, Alexander J ^a   Musiime, Victor ^b,c   Bwakura Dangarembizi, Mutsawashe ^d   Nahirya Ntege, Patricia ^e   Kekitiinwa, Adeodata ^f,h   Gibb, Diana M ^a   Nathoo, Kusum ^d   Prendergast, Andrew J ^a,g   Walker, A Sarah ^a   Munderi, P ^e   Katuramu, R ^e   Lutaakome, J ^e   Nankya, F ^e   Nabulime, G ^e   Sekamatte, I ^e   Kyarimpa, J ^e   Ruberantwari, A ^e   Sebukyu, R ^e   Tushabe, G ^e   Wangi, D ^e   Musinguzi, M ^e   Aber, M ^e   Matama, L ^e   Nakitto Kesi, D ^e   Mugyenyi, P ^b   Keishanyu, R ^b   Afayo, V D ^b   Bwomezi, J ^b   Byaruhanga, J ^b   Erimu, P ^b   Karungi, C ^b   Kizito, H ^b   Namala, W S ^b   Namusanje, J ^b   Nandugwa, R ^b   Najjuko, T K ^b   Natukunda, E ^b   Ndigendawani, M ^b   Nsiyona, S O ^b   Kibenge, R ^b   Bainomuhwezi, B ^b   Sseremba, D ^b   Tezikyabbiri, J ^b   Tumusiime, C S ^b   Balaba, A ^b   Mugumya, A ^b   Nghania, F ^b   Mwebesa, D ^b   Mutumba, M ^b   Bagurukira, E ^b   Odongo, F ^b   Mubokyi, S ^b   Ssenyonga, M ^b   Kasango, M ^b   Lutalo, E ^b   Oronon, P ^b   Bwakura Dangarembizi, M F ^d   Mapinge, F ^d   Chidziva, E ^d   Mhute, T ^d   Vhembo, T ^d   Mandidewa, R ^d   Chipiti, M ^d   Dzapasi, R ^d   Katanda, C ^d   Nyoni, D ^d   Tinago, G C ^d   Bhiri, J ^d   Mudzingwa, S ^d   Muchabaiwa, D ^d   Phiri, M ^d   Masore, V ^d   Marozva, C C ^d   Maturure, S J ^d   Tsikirayi, S ^d   Munetsi, L ^d   Rashirai, K M ^d   Steamer, J ^d   Nhema, R ^d   Bikwa, W ^d   Tambawoga, B ^d   Mufuka, E ^d   Musoke, P ^h   Bakeera Kitaka, S ^h   Namuddu, R ^h   Kasirye, P ^h   Babirye, A ^h   Asello, J ^h   Nakalanzi, S ^h   Ssemambo, N C ^h   Nakafeero, J ^h   Tikabibamu, J ^h   Musoba, G ^h   Ssanyu, J ^h   Kisekka, M ^h   Gibb, D M ^a   Thomason, M J ^a   Cook, A D ^a   Naidoo James, B ^a   Spyer, M J ^a   Male, C ^a   Glabay, A J ^a   Kendall, L K ^a   Crawley, J ^a   Machingura, I ⁱ   Ssenyonjo, S ⁱ   Weller, I ⁱ   Luyirika, E ⁱ   Lyall, H ⁱ   Malianga, E ⁱ   Mwansambo, C ⁱ   Nyathi, M ⁱ   Miiro, F ⁱ   Kinn, S ⁱ   McNeil, M ⁱ   Roberts, M ⁱ   Snowden, W ⁱ   Breckenridge, A ⁱ   Pozniak, A ⁱ   Hill, C ⁱ   Matenga, J ⁱ   Tumwine, J ⁱ   Tudor Williams, G ⁱ   Barigye, H ⁱ   Mujuru, H A ⁱ   Ndeezi, G ⁱ   Prendergast, A ⁱ   Spyer, M ⁱ   Revill, P ⁱ   Mabugu, T ⁱ   Mirimo, F ⁱ   Walker, S ⁱ   Sculpher, M J ⁱ   more..

^a UNIVERSITY COLLEGE LONDON   (United Kingdom)

^b JOINT CLINICAL RESEARCH CENTRE   (Uganda)

^c MAKERERE UNIVERSITY   (Uganda)

^d UNIVERSITY OF ZIMBABWE   (Zimbabwe)

^e UGANDA VIRUS RESEARCH INSTITUTE   (Uganda)

^f MULAGO HOSPITAL   (Uganda)

^g QUEEN MARY UNIVERSITY OF LONDON   (United Kingdom)

^h Baylor College of Medicine Children's Foundation Uganda Mulago Hospital Uganda   (France)

ⁱ NONE

Author keywords

Africa; antiretroviral therapy; children; HIV; puberty

Indexed keywords

ABACAVIR; EFAVIRENZ; LAMIVUDINE; NEVIRAPINE; ZIDOVUDINE; ANTIRETROVIRUS AGENT;

ADOLESCENT; ANTIVIRAL THERAPY; ARTICLE; BODY BUILD; BODY HEIGHT; BODY MASS; CD4+ T LYMPHOCYTE; CHILD; CONTROLLED STUDY; DELAYED PUBERTY; FEMALE; GROWTH ACCELERATION; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNOSUPPRESSIVE TREATMENT; INFANT; MAJOR CLINICAL STUDY; MALE; MENARCHE; PRIORITY JOURNAL; PUBERTY; RANDOMIZED CONTROLLED TRIAL; SKINFOLD THICKNESS; STAGING; UGANDAN; ZIMBABWEAN; ADOLESCENT DEVELOPMENT; ANTHROPOMETRY; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HIV INFECTIONS; PRESCHOOL CHILD; PROCEDURES; UGANDA; ZIMBABWE;

ADOLESCENT; ADOLESCENT DEVELOPMENT; ANTHROPOMETRY; ANTI-RETROVIRAL AGENTS; ANTIRETROVIRAL THERAPY, HIGHLY ACTIVE; CHILD; CHILD, PRESCHOOL; FEMALE; HIV INFECTIONS; HUMANS; INFANT; MALE; UGANDA; ZIMBABWE;

EID: 84926505428     PISSN: 02699370     EISSN: 14735571     Source Type: Journal    
DOI: 10.1097/QAD.0000000000000590     Document Type: Article

References (29)

1. World Health Organisation. Global update on HIV treatment 2013. Geneva: World Health Organisation; 2013.
2. Joint United Nations Programme on HIV/AIDS. Global report: UNAIDS report on the global AIDS epidemic 2013. Geneva: UNAIDS; 2013.
3. World Health Organisation. Antiretroviral therapy for HIV infection in infants and children: towards universal access. Recommendations for a public health approach. Geneva: World Health Organisation; 2010.
4. World Health Organisation. Consolidated guidelines on the use of antiretroviral drugs for treating and preventing HIV infection: Recommendations for a public health approach. Geneva: World Health Organisation; 2013.
5. Bernays S, Jarrett P, Kranzer K, Ferrand RA. Children growing up with HIV infection: the responsibility of success. Lancet 2014; 383:1355-1357.
6. De Martino M, Tovo P-A, Galli L, Gabiano C, Chiarelli F, Zappa M, et al. Puberty in perinatal HIV-1 infection: a multicentre longitudinal study of 212 children. AIDS 2001; 15:1527-1534.
7. Buchacz K, Rogal AD, Lindsey JC, Wilson CM, Hughes MD, Seage GRI, et al. Delayed onset of pubertal development in children and adolescents with perinatally acquired HIV infection. J Acquir Immune Defic Syndr 2003; 33:56-65.
8. Williams PL, Abzug MJ, Jacobson DL, Wang J, Van Dyke RB, Hazra R, et al. Pubertal onset in children with perinatal HIV infection in the era of combination antiretroviral treatment. AIDS 2013; 27:1959-1970.
9. Bakeera-Kitakaa S, McKellarb M, Sniderb C, Kekitiinwaa A, Piloyaa T, Musokea P, et al. Antiretroviral therapy for HIV-1 infected adolescents in Uganda: assessing the impact on growth and sexual maturation. J Pediatr Infect Dis 2008; 3: 97-104.
10. World Health Organisation. Antiretroviral therapy for HIV infection in infants and children: Towards universal access. Recommendations for a public health approach. http://www.who.int/hiv/pub/guidelines/paediatric020907.pdf.
11. ARROW Trial team. Routine versus clinically driven laboratory monitoring and first-line antiretroviral therapy strategies in African children with HIV (ARROW): a 5-year open-label randomised factorial trial. Lancet 2013; 381:1391-1403.
12. Tanner JM, Whitehouse RH. Clinical longitudinal standards for height, weight, height velocity, weight velocity, and stages of puberty. Arch Dis Child 1976; 51:170-179.
13. Lohman TG, Roche AF, Martorell R. Anthropometric standardization reference manual. Champaign, IL: Human Kinetics Books; 1988.
14. De Onis M, Onyango AW, Borghi E, Siyam A, Nishida C, Siekmanna J. Development of a WHO growth reference for school-aged children and adolescents. Bull World Health Organ 2007; 85:660-667.
15. WHO Multicentre Growth Reference Study Group. WHO child growth standards: length/height-for-age, weight-for-age, weightfor-length, weight-for-height and body mass index-for-age: methods and development. Geneva: World Health Organisation; 2006.
16. Gerver WJM, de Bruin R. Paediatric morphometrics: a reference manual. Maastricht: Universitaire Pers Maastricht; 2001.
17. Fredriks AM, van Buuren S, Fekkes M, Verloove-Vanhorick SP, Wit JM. Are age references for waist circumference, hip circumference and waist-hip ratio in Dutch children useful in clinical practice? Eur J Pediatr 2005; 164:216-222.
18. Euling SY, Herman-Giddens ME, Lee PA, Selevan SG, Juul A, Sørensen TIA, et al. Examination of US puberty: timing data from 1940 to 1994 for secular trends: panel findings. Pediatrics 2008; 121:S172-S191.
19. Parent A-S, Teilmann G, Juul A, Skaakebaek NE, Toppari J, Bourguignon J-P. The timing of normal puberty and the age limits of sexual precocity: variations around the world, secular trends, and changes after migration. Endocr Rev 2003; 24:668-693.
20. Hess K. Assessing time-by-covariate interactions in proportional hazards regression models using cubic spline functions. Stat Med 1994; 13:1045-1062.
21. Picat M-Q, Lewis J, Musiime V, Prendergast A, Nathoo K, Kekitiinwa A, et al. Predicting patterns of long-term CD4 reconstitution in HIV-infected children starting antiretroviral therapy in sub-Saharan Africa: a cohort-based modelling study. PLoS Med 2013; 10:e1001542.
22. The Republic of Uganda Ministry of Health. Addendum to the national antiretroviral treatment guidelines. Kampala: The Republic of Uganda Ministry of Health; 2014.
23. Walters TD, Griffiths AM. Mechanisms of growth impairment in pediatric Crohn's disease. Nat Rev Gastroenterol Hepatol 2009; 6:513-523.
24. Karpati AM, Rubin CH, Kieszak SM, Marcus M, Troiano RP. Stature and pubertal stage assessment in American boys: the 1988-1994 Third National Health and Nutrition Examination Survey. J Adolesc Health 2002; 30:205-212.
25. Wu T, Mendola P, Buck GM. Ethnic differences in the presence of secondary sex characteristics and menarche among US girls: the Third National Health and Nutrition Examination Survey, 1988-1994. Pediatrics 2002; 110:752-757.
26. Prentice AM, Ward KA, Goldberg GR, Jarjou LM, Moore SE, Fulford AJ, et al. Critical windows for nutritional interventions against stunting. Am J Clin Nutr 2013; 97:911-918.
27. Arpadi SM, Bethel J, Horlick M, Sarr M, Bamji M, Abrams EJ, et al. Longitudinal changes in regional fat content in HIVinfected children and adolescents. AIDS 2009; 23:1501-1509.
28. Alves C, Oliveira AC, Brites C. Lipodystrophic syndrome in children and adolescents infected with the human immunodeficiency virus. Braz J Infect Dis 2008; 12:342-348.
29. Hergenroeder AC, Hill RB, Wong WW, Sangi-Haghpeykar H, Taylor W. Validity of self-assessment of pubertal maturation in African American and European American adolescents. J Adolesc Health 1999; 24:201-205.